ReportGem ReportGem

REAL-TIME GLOBAL RESEARCH

Quick Take: Sino Biopharm 1H26 beat led by innovative drug sales and license income

Published: 2026-08-19Institution: BernsteinCompany / ticker: 1177.HKPages: 13Original language: English
Bernstein research

Research evidence excerpt

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer

Related research and intelligence

US Industrials: 30 exhibits on the state of cooling and electrical equip. procurement in North American Data Centers: U.S. Multi Industry & Electrical Equipment2026-08-20 · BernsteinQuick Take – DE 3Q26: beat & raise on better performance & tariff refunds; EOP commentary to take the stage2026-08-20 · BernsteinVisa, Mastercard: Time to rethink/revisit the U.S. Card growth debate?2026-08-20 · BernsteinUS Biotechnology: Roivant and Immunovant - Post 1Q27 Model Update2026-08-20 · BernsteinQuick Take: Walmart 2Q27 - WMT US comp weak as expected; buy on weakness?2026-08-20 · BernsteinAMEC 2Q26: Accelerating order growth, resilient supply chain2026-08-20 · Bernstein